Figue/table Captions
Visual abstract: Myelofibrosis patients with a PD-L1 score
<250 had a median overall survival of 130 months vs PD-L1
score >250 of 64 months, P=0.09.
Figure 1.76 y/o woman with JAK2 positive PMF (Expression 100%,
intensity +3)
Figure 2. 28 y/o woman with anemia and normal BM BX (Expression 0%,
intensity 0)
Figure 3. 73 y/o woman with JAK2 negative PMF (Expression 78%,
intensity +2)
Figure 4. 60 y/o man with JAK2 negative PMF (Expression 100%, intensity
+3)
Table 1.- Main characteristics of patients with myelofibrosis.
Table 2.- Level of expression and intensity of PD-L1 on the 29 bone
marrow biopsies
Figure 5.- Median Overall Survival according to a PD-L1 socre
>250 vs <250.